Literature DB >> 9933856

Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.

S Rososhansky1, M C Badonnel, L L Hiestand, M A Popovsky, I O Szymanski.   

Abstract

OBJECTIVES: We determined which of the 22 blood components obtained from unrelated donors and transfused to an apparently immunocompetent patient following open heart surgery caused transfusion-associated graft-versus-host disease (TA-GVHD).
METHODS: Serologic and molecular methods were used to type the donors, the patient's family members, and the patient's postmortem tissues for HLA and a genetic marker on chromosome 17.
RESULTS: Two donors were homozygous for the HLA class I antigens A1 B8, for which the patient was heterozygous. Both donors were heterozygous, not homozygous as expected, for the class II alleles. One of them had the same class II alleles as the patient (DRB1*0301, DRB3*0101/DRB1*0404, DRB4*0103). The patient's tissues were chimeric for restriction fragments at 17p13 of this donor.
CONCLUSION: One-way HLA match leading to TA-GVHD can be caused by donor blood that is homozygous for class I and heterozygous for class II alleles. Two blood components given to our patient had such one-way HLA match. Class II alleles of the lymphocytes in one component were identical with those of the recipient and caused TA-GVHD. Class II alleles of the lymphocytes in the other component differed from those of the recipient and were eliminated either by the immune system of the patient or the lymphocytes that caused the TA-GVHD (graft versus graft).

Entities:  

Mesh:

Year:  1999        PMID: 9933856     DOI: 10.1159/000031021

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  3 in total

Review 1.  Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.

Authors:  Eleftherios C Vamvakas; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2010-04

2.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

3.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.